Literature DB >> 15851549

Persistent hyperplastic primary vitreous in transgenic mice expressing IE180 of the pseudorabies virus.

Satoshi Taharaguchi1, Kazuhiko Yoshida, Yukiko Tomioka, Saori Yoshino, Toshimitsu Uede, Etsuro Ono.   

Abstract

PURPOSE: Pseudorabies virus (PRV), a representative member of the alpha-herpesvirus family, causes nervous symptoms and ocular lesions, such as keratoconjunctivitis and retinal degeneration in piglets. The immediate-early protein IE180 of the PRV is known to be essential, not only in viral gene expression, but also in the cellular gene expression in host cells. The purpose of this study was to examine the effect of IE180 on the development of the mouse eye, by using transgenic technology.
METHODS: Transgenic mice expressing IE180 were generated and their eyes analyzed by histology, immunocytochemistry, and the bromodeoxyuridine cell proliferation assay.
RESULTS: A fibrovascular retrolental tissue analogous to persistent hyperplastic primary vitreous (PHPV) in humans was observed in a transgenic mouse line expressing IE180. The gross anatomy of the eye showed white pupils. Analysis of hematoxylin and eosin-stained sections revealed that the retrolental tissue adhered to the neuroretina, the inner nuclear and ganglion cell layers were disorganized, and rosettelike arrangements of dysplastic photoreceptor cells were present. Bromodeoxyuridine-positive cells were detected in the retrolental tissues of postnatal day (P)1, P7, and P14 mice. The retrolental mass in the P7 transgenic mouse was composed of melanocytes and endothelial cells, which were detected by a cocktail of antibodies against endoglin, CD31, and VEGF receptor-2.
CONCLUSIONS: The observation that the eye disease in transgenic mice is similar to that in PHPV in humans raises the possibility that expression of the immediate-early gene of alpha-herpesviruses may contribute to PHPV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851549     DOI: 10.1167/iovs.04-0743

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Microphthalmia and lack of vitreous body in transgenic mice expressing the first immunoglobulin-like domain of nectin-1.

Authors:  Kazuhiko Yoshida; Yukiko Tomioka; Satoru Kase; Masami Morimatsu; Kyoko Shinya; Shigeaki Ohno; Etsuro Ono
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-17       Impact factor: 3.117

2.  A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye.

Authors:  Yanbin Zheng; Caitlin Devitt; Jing Liu; Jie Mei; Stephen X Skapek
Journal:  Dev Biol       Date:  2013-05-09       Impact factor: 3.582

3.  Proceedings of the 2015 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Cindy A Farman; James R Hailey; Ramesh C Kovi; David E Malarkey; James P Morrison; Jennifer Neel; Patricia A Pesavento; Brian F Porter; Kathleen A Szabo; Leandro B C Teixeira; Erin M Quist
Journal:  Toxicol Pathol       Date:  2016-04-12       Impact factor: 1.902

4.  Varied manifestations of persistent hyperplastic primary vitreous with graded somatic mosaic deletion of a single gene.

Authors:  Michelle N Mary-Sinclair; Xiaofei Wang; Douglas J Swanson; Caroline Y Sung; Eneida A Mendonca; Kristen Wroblewski; Shannon H Baumer; Dan Goldowitz; Monica M Jablonski; Stephen X Skapek
Journal:  Mol Vis       Date:  2014-03-03       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.